Early Phase (BA/BE & Phase I)

Early Phase (BA/BE & Phase I)
Product Description

Established in Year 2004, Cliantha has supported more than 500+ clients in conducting > 7500+, Phase-I, BA-BE studies, Patient Based PK studies, Clinical End-point studies (Phase-II to Phase-IV) & IVRT/IVPT studies. We provide following full scope services to Pharmaceutical / Biotech companies and support them in their Clinical Development journey.

Cliantha Research Limited

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Research Organisation (CRO)
Primary activities
Clinical Research

Cliantha Research Limited

  • Country/Region:
    India
  • On CPHI since:
    2019
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Contract Research Organisation (CRO)
Primary activities
Clinical Research

More Products from Cliantha Research Limited (3)

  • Biometrics

    Product Biometrics

    This division focuses on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. As experts in clinical data, Cliantha provides competent outsourcing solutions for Clinical Data Management, Biostatistics, Statistical Programming. We can offer study level suppor...
  • Lab Services

    Product Lab Services

    Cliantha Research provides scientific expertise with state-of-the-art technologies reinforced by commitment for quality delivery. Our comprehensive lab services include central lab testing, bioanalytical, Pharmacokinetics (PK) services, Immunogenicity (ADA), Bio marker, Vaccine Immunogenicity testing. 800...
  • Late Phase (Clinical Trials)

    Product Late Phase (Clinical Trials)

    2025+ Late Phase Studies, 25+ Therapeutic Categories, 100+ Indications, 5000+Sites, 51000+Patients, 75+ USFDA Site Audits , Therapeutic Categories Experience: Oncology, Biosimilars, Neuropsychiatry, Dermatology, Respiratory, Gastrointestinal, Ophthalmology, Neurology, Endocrinology, Immune Disorder, Inf...

Cliantha Research Limited resources (4)

  • Brochure BABE and Phase I Studies

    7000+ Studies. Inspected by:USFDA, GCC, EMA, AGES, ANSM, ANVISA, AMPS, MCC South Africa, Health Canada, Malaysia NPRA, DCGI, CAP, NABL, Turkey MOH,Thailand MoPH
  • Brochure Late Phase Studies

    200+ Late Phase Studies, 25+ Therapeutic Categories, 100+ Indications, 2000+Sites, 31000+Patients, 60+ USFDA Site Audits
  • Brochure Lab Services

    Our lab services include central lab testing, bioanalytical, Pharmacokinetics (PK) services, Immunogenicity (ADA), Bio marker, Vaccine Immunogenicity testing.
  • Brochure Biometrics

    Cliantha provides competent outsourcing solutions for Clinical Data Management, Biostatistics, Statistical Programming.